| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.22 | 0.001 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |